News & Press Releases

Press Release

May 11, 2026

Andelyn Biosciences Launches LVV Curator® Platform, Bringing Proven Viral Vector Platform Pedigree to Lentiviral Vector Manufacturing for Cell TherapiesAndelyn Biosciences Launches LVV Curator® Platform, Bringing Proven Viral Vector Platform Pedigree to Lentiviral Vector Manufacturing for Cell Therapies
News

April 24, 2026

Andelyn Biosciences and ENCell partner to create US-APAC gene therapy manufacturing corridorAndelyn Biosciences and ENCell partner to create US-APAC gene therapy manufacturing corridor
News

April 22, 2026

Andelyn and ENCell partner to accelerate global delivery of gene therapiesAndelyn and ENCell partner to accelerate global delivery of gene therapies
News

April 22, 2026

Andelyn Biosciences, ENCell Enter Strategic Gene Therapy Manufacturing Pact Andelyn Biosciences, ENCell Enter Strategic Gene Therapy Manufacturing Pact
News

April 22, 2026

Andelyn, ENCell team on global gene therapy manufacturingAndelyn, ENCell team on global gene therapy manufacturing
Press Release

April 21, 2026

Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy ManufacturingAndelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing
Press Release

April 14, 2026

Andelyn Biosciences Partners with Evolyra Therapeutics for the Clinical Manufacturing of Gene Therapies for the Treatment of Limb-Girdle Muscular Dystrophies Andelyn Biosciences Partners with Evolyra Therapeutics for the Clinical Manufacturing of Gene Therapies for the Treatment of Limb-Girdle Muscular Dystrophies
News

March 18, 2026

Creating Sustainable Operational Excellence in Pharma ManufacturingCreating Sustainable Operational Excellence in Pharma Manufacturing
Press Release

March 10, 2026

Andelyn Biosciences Establishes The Andelyn Foundation to Support Families Living with Rare and Ultra-Rare DiseasesAndelyn Biosciences Establishes The Andelyn Foundation to Support Families Living with Rare and Ultra-Rare Diseases
Press Release

February 17, 2026

Andelyn Biosciences to Apply the AAV Curator® Platform to Manufacture Clinical Grade AAV for Drake Rayden Foundation for the Treatment of Nonketotic HyperglycinemiaAndelyn Biosciences to Apply the AAV Curator® Platform to Manufacture Clinical Grade AAV for Drake Rayden Foundation for the Treatment of Nonketotic Hyperglycinemia
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
PreferencesDenyAccept